ClinicalTrials.Veeva

Menu

Blood Coagulation Profile After Liver Resection.

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Completed

Conditions

Coagulation Disorder

Treatments

Diagnostic Test: thromboelastography (TEG®6s)

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Liver resection is the treatment of choice in patients with primary or metastatic liver neoplasms, benign liver neoplasms and numerous biliary diseases. In these patients, in the postoperative period,several factors can induce a transient alteration of the synthesis hepatic coagulation factors such as size of the lesion liver, underlying liver disease (e.g. malignancy), pre-existing cirrhosis, duration of both surgery and vascular clamping, and blood loss. So far, some studies have shown that conventional coagulation tests indicate a hypocoagulable state which may lead to excessive transfusions of blood products or an increased risk of thromboembolic events related to delayed initiation of thromboprophylaxis in the postoperative period. In an attempt to optimizing the state of coagulation, recently there is increased interest for viscoelastic coagulation testing (thromboelastography and rotational thromboelastometry). The results of these studies have shown that these patients often have a hypercoagulable and non hypocoagulable profile as evidenced by conventional coagulation tests.

the purpose of the study is to evaluate whether the combination of coagulation tests conventional systems and new thromboelastography can increase the quality of surveillance of the coagulation state after liver surgery, in order to optimize the management of postoperative blood coagulation of these patients.

Enrollment

46 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elective liver resection surgery for liver cancer primary or metastatic
  • Admission to surgical intensive care unit at the end of the surgery.

Exclusion criteria

  • Renal disease (creatinine clearance < 30 ml/min)
  • pregnancy
  • Benign liver disease
  • Emergency surgery
  • Reintervention

Trial contacts and locations

1

Loading...

Central trial contact

rita rg gaspari, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems